Tachykinins in the porcine pancreas: potent exocrine and endocrine effects via NK-1 receptors.
The localization, release, and effects of substance P and neurokinin A were studied in the porcine pancreas and the localization of substance P immunoreactive nerve fibers was examined by immunohistochemistry. The effects of electrical vagus stimulation and capsaicin infusion on tachykinin release and the effects of substance P and neurokinin A infusion on insulin, glucagon, somatostatin, and exocrine secretion were studied using the isolated perfused porcine pancreas with intact vagal innervation. NK-1 and NK-2 receptor antagonists were used to investigate receptor involvement. Substance P immunoreactive nerve fibers were localized to islets of Langerhans, acini, ducts, and blood vessels. Vagus stimulation had no effect on substance P and neurokinin A release, whereas capsaicin infusion stimulated release of both. Substance P and neurokinin A infusion increased release of insulin, glucagon, and exocrine secretion, whereas somatostatin secretion was unaffected. The effect of substance P on insulin, glucagon, and exocrine secretion was blocked by the NK-1 receptor antagonist. The effect of electrical stimulation of vagus nerves on insulin and exocrine secretion was not influenced by tachykinin receptor antagonists. We conclude that tachykinins stimulate both endocrine and exocrine pancreatic functions through NK-1 receptors. Tachykinins are not involved in vagal regulation of pancreatic secretion in pigs but could constitute part of an alternative stimulatory system.
Schmidt
P T
PT
Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark.
Tornøe
K
K
Poulsen
S S
SS
Rasmussen
T N
TN
Holst
J J
JJ
D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D004558:Electric Stimulation; D005934:Glucagon / Q000378:metabolism; D007150:Immunohistochemistry; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D009412:Nerve Fibers / Q000737:chemistry; D015288:Neurokinin A / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology; D010179:Pancreas / Q000737:chemistry / Q000294:innervation / Q000502:physiology*; D018040:Receptors, Neurokinin-1 / Q000502:physiology*; D013004:Somatostatin / Q000378:metabolism; D013373:Substance P / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology; D013552:Swine; D015320:Tachykinins / Q000032:analysis* / Q000378:metabolism* / Q000494:pharmacology; D014630:Vagus Nerve / Q000502:physiology
D007328:Insulin; D018040:Receptors, Neurokinin-1; D015320:Tachykinins; D013373:Substance P; D013004:Somatostatin; D015288:Neurokinin A; D005934:Glucagon; D002211:Capsaicin